• EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1

  2026-05-24

  EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent designed for controlled amide bond formation in peptide synthesis, bioconjugation, and nucleotide coupling workflows. It is strictly intended for in vitro laboratory applications and should not be used in in vivo or clinical contexts due to the absence of supporting data.

• Luminescent ATP Cell Viability Assay Kit I: Precision for Fe

  2026-05-23

  The Luminescent ATP Cell Viability Assay Kit I empowers researchers with ultra-sensitive, rapid cell viability measurement, essential for dynamic studies of regulated cell death like ferroptosis. With a streamlined, no-lysis workflow and robust luminescence detection, it outperforms legacy assays in applications from cancer research to high-throughput drug screening.

• Cy5 maleimide (non-sulfonated): Practical Guide for Cysteine

  2026-05-22

  Cy5 maleimide (non-sulfonated) offers site-specific fluorescent labeling of proteins and peptides via cysteine residues, supporting reliable probe generation for imaging and assay workflows. It is best used where thiol selectivity and high extinction coefficient are required, but is not suitable for protocols demanding high aqueous solubility or amine-reactive labeling.

• Anlotinib Hydrochloride: Advanced Mechanisms and Strategic I

  2026-05-22

  Explore the molecular mechanisms and strategic research applications of Anlotinib hydrochloride, a leading multi-target tyrosine kinase inhibitor. This article offers a deep, evidence-based analysis of its anti-angiogenic action, bridging bench protocols with translational potential in cancer research.

• 4-Hydroxytamoxifen: Protocol Parameters and Workflow Guidanc

  2026-05-21

  4-Hydroxytamoxifen is a potent estrogen receptor modulator designed for research protocols where precise control of estrogen receptor activity is required, such as breast or prostate cancer studies and cardiac myocyte calcium assays. It should not be used in workflows requiring aqueous or ethanol solubility and demands rigorous DMSO-based preparation and cold storage for reproducibility.

• S-Adenosylmethionine: Optimizing Methylation in CNS Research

  2026-05-21

  S-Adenosylmethionine (SAM) empowers researchers to execute high-fidelity methylation assays critical for both epigenetic research and central nervous system (CNS) disorder models. This guide breaks down advanced experimental workflows, troubleshooting, and protocol enhancements, leveraging the latest translational insights for superior reproducibility and biological impact.

• Exo1 in Exocytic Pathway Research: Precision with Methyl 2-(

  2026-05-20

  Exo1 (methyl 2-(4-fluorobenzamido)benzoate) enables acute, selective inhibition of membrane trafficking with a mechanism distinct from classic agents like BFA. This guide details optimized workflows, troubleshooting strategies, and how Exo1 advances exocytic pathway research and experimental clarity.

• Intestinal TM6SF2 Maintains Gut–Liver Axis to Protect Agains

  2026-05-20

  This study demonstrates that intestinal TM6SF2 is crucial for preventing metabolic dysfunction-associated steatohepatitis (MASH) by sustaining gut barrier integrity and modulating host–microbiome interactions. The findings introduce new mechanistic insight into the gut–liver axis and suggest potential intervention strategies targeting lipid signaling and microbiota for MASH.

• Light-Inducible RNA Switches Enable On-Demand Gene Therapy C

  2026-05-19

  A recent study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that enables precise, reversible control of mRNA translation in vivo. This approach offers a compact and clinically compatible strategy for regulating gene therapies, with significant implications for chronic metabolic and retinal disease treatment.

• Structure-Based Screening Identifies NSP15 Inhibitors for SA

  2026-05-19

  The referenced study applies structure-based virtual screening and molecular dynamics to identify thymopentin and oleuropein as potent inhibitors of the SARS-CoV-2 NSP15 endoribonuclease. These findings highlight new directions for antiviral drug discovery targeting viral immune evasion mechanisms.

• Dynasore: Benchmarking a Dynamin GTPase Inhibitor for Endocy

  2026-05-18

  Dynasore is a validated, cell-permeable dynamin GTPase inhibitor used in endocytosis research. It provides reversible, dose-dependent blockade of dynamin-mediated vesicle scission. APExBIO’s Dynasore (SKU A1605) is a reference standard for dissecting clathrin-mediated pathways in cellular models.

• Dronedarone (Multaq): Mechanistic Horizons in AF Research

  2026-05-18

  This article provides translational researchers with a mechanistic and strategic roadmap for leveraging Dronedarone (Multaq) in atrial fibrillation (AF) and atrial flutter research. Drawing on recent evidence, it clarifies the agent's multi-ion channel action, its limitations regarding KCa2 channel selectivity, and how high-purity Dronedarone from APExBIO empowers advanced cardiac arrhythmia pharmacology studies. The discussion integrates protocol guidance, competitive insights, and a forward-looking perspective on atrial-selective targets.

• Propranolol: Integrative Mechanisms in Cardiovascular and Me

  2026-05-17

  Explore Propranolol as a non-selective β-adrenergic receptor blocker in cardiovascular regulation and emotional memory modulation. This article delivers a multi-system scientific analysis, bridging metabolic, neurobiological, and translational research gaps for advanced experimental design.

• Streptavidin-Cy3: Precision Biotin Detection in Epigenomic N

  2026-05-16

  Explore how Streptavidin-Cy3 enables high-fidelity biotin detection for advanced epigenomic and metastatic analysis in nasopharyngeal carcinoma (NPC) research. This article delivers a distinct, protocol-driven perspective on leveraging streptavidin cy3 conjugates for interrogating chromatin architecture and RNA-protein interactions.

• SZQ-3 Chromone–Maleimide Hybrid Modulates NF-κB to Combat Os

  2026-05-15

  This study identifies SZQ-3, a synthetic chromone–maleimide hybrid, as a dual-acting modulator of osteoblast and osteoclast function via mitochondrial and NF-κB pathway regulation. The findings demonstrate SZQ-3’s capacity to prevent postmenopausal osteoporosis in vitro and in vivo, highlighting new therapeutic directions for bone disease with improved safety profiles.

449 records 17/30 page Previous Next First page 上5页 1617181920 下5页 Last page